Featured News

We are pleased to announce our newest online resource for patients and caregivers to drive policy change to improve the health of those living with celiac disease and accelerate research: iAdvocate.

On Friday, I joined three of the leading celiac disease researchers in the world to present to the NIH’s Autoimmune Disease Coordinating Committee (ADCC) the findings from the CDF-sponsored First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020.

We have been hearing from our community about COVID-19 and celiac disease and about our work at the Celiac Disease Foundation during the pandemic. We have answered the most frequently asked questions in a short video for you. 

The Voluntary Recommendations for Managing Celiac Disease in Learning Environments provides definitive guidance for schools, parents and caregivers for 504 accommodations for children with celiac disease. Download the guide and watch the video.

Confronted with the reality of an all-consuming global pandemic, every nonprofit, including the Celiac Disease Foundation, has to figure out where we fit in a world that is quickly changing and into a future that no one can predict.

Last week, one of our 2019 Young Investigator Award recipients, Dr. Benjamin Lebwohl, co-authored a study that showed a small, but statistically significant increase in mortality rates for patients with celiac disease.

Dr. Dan Leffler, Celiac Disease Foundation Medical Advisory Board Member and clinician and researcher at Harvard Medical School and Takeda, spoke about the profound ineffectiveness and failure of the gluten-free diet as a treatment for celiac disease.

Even in the midst of the COVID-19 pandemic, celiac disease patients need treatments and a cure. On March 8, the Celiac Disease Foundation sponsored the First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020 to inform NIH funding needs.

2020 is starting out BIG, with the Celiac Disease Foundation hosting the National Celiac Disease Patient Advocacy Summit on February 27, 2020, in Washington, DC. Apply today to attend.

After decades of pleading with our federal government to take celiac disease as seriously as it does other diseases with comparable patient impact, yesterday, the U.S. House and Senate each passed, and President Trump has signed, the FY2020 Federal budget resolution.